Virbac SA (FR:VIRP)
:VIRP
Want to see FR:VIRP full AI Analyst Report?
VIRP Stock Chart & Stats
€359.00
-€0.50(-0.16%)
At close: 4:00 PM EST
€359.00
-€0.50(-0.16%)
Day’s Range― - ―
52-Week Range€296.00 - €389.50
Previous CloseN/A
Volume40.00
Average Volume (3M)5.07K
Market Cap
€2.89B
Enterprise Value€3.18B
Total Cash (Recent Filing)€122.50M
Total Debt (Recent Filing)€295.26M
Price to Earnings (P/E)19.2
Beta0.71
Next Earnings
Sep 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.41%
Share Statistics
EPS (TTM)17.98
Shares Outstanding8,390,660
10 Day Avg. Volume4,115
30 Day Avg. Volume5,072
Financial Highlights & Ratios
PEG Ratio5.39
Price to Book (P/B)2.67
Price to Sales (P/S)2.05
P/FCF Ratio29.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€415.00Price Target Upside15.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)20.32
Revenue Forecast (FY)€1.54B
Bulls Say, Bears Say
Bulls Say
Geographic GrowthEurope and Latin America are posting solid growth rates of around +8%, and the Group is off to a good start for the year.
Guidance ConfirmationThe Group confirmed its FY25 guidance, which implies +3% adj. EBIT 25E growth.
Market PositionThe Group's product and geographic mix should enable it to continue to slightly outperform its market for a few more years.
Bears Say
Earnings GrowthSlowdown of earnings growth likely to continue in H1-25 due to an unfavourable base effect.
Regional PerformanceAustralia is still down sharply (-15%) and momentum is soft in the USA (+2.7%) and Asia.
Virbac SA News
VIRP FAQ
What was Virbac SA’s price range in the past 12 months?
Virbac SA lowest stock price was €296.00 and its highest was €389.50 in the past 12 months.
What is Virbac SA’s market cap?
Virbac SA’s market cap is €2.89B.
When is Virbac SA’s upcoming earnings report date?
Virbac SA’s upcoming earnings report date is Sep 17, 2026 which is in 98 days.
How were Virbac SA’s earnings last quarter?
Virbac SA released its earnings results on Mar 17, 2026. The company reported €8.174 earnings per share for the quarter, beating the consensus estimate of N/A by €8.174.
Is Virbac SA overvalued?
According to Wall Street analysts Virbac SA’s price is currently Undervalued.
Does Virbac SA pay dividends?
Virbac SA pays a Annually dividend of €1.45 which represents an annual dividend yield of 0.41%. See more information on Virbac SA dividends here
What is Virbac SA’s EPS estimate?
Virbac SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Virbac SA have?
Virbac SA has 8,390,660 shares outstanding.
What happened to Virbac SA’s price movement after its last earnings report?
Virbac SA reported an EPS of €8.174 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.826%.
Which hedge fund is a major shareholder of Virbac SA?
Currently, no hedge funds are holding shares in FR:VIRP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Virbac SA
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
VIRP Stock 12 Month Forecast
Average Price Target
€415.00
▲(15.60% Upside)
Technical Analysis
Options Prices
Currently, No data available
---